All posts by imreal

Salesian Missions sends critical shipment of medical and food aid


“We appreciate this new partnership with Matter, which has enabled us to get critical medical supplies to places in need in Ukraine,” said Father Gus Baek, director of Salesian Missions.

UKRAINE: Salesian Missions sends critical shipment of medical and food aid

Donations impacted more than 1,000 people.

Salesian missionaries in Ukraine have medical supplies and rice-meals to aid people thanks to donations secured and shipped by Salesian Missions, the U.S. development arm of the Salesians of Don Bosco. Salesians living and working in Ukraine* have remained in their centers and churches where they are helping families with shelter, support, and nutrition. The donations impacted more than 1,000 people.

The medical supply donation was provided by Matter, an organization that provides valuable corporate surplus to the places and people who need these life-saving resources the most. The medical supplies were provided to the Daughters of Mary Help of Christians of the Eastern Rite in Ukraine and then dispersed to the Salesian community in Zhytomyr, among other sites. The supplies are being used in local hospitals and for people in need.

Katie Johnson, director of global health initiatives at Matter, said, “The team at Salesian Missions is doing wonderful work and Matter is honored to partner with such a special organization. We are grateful for organizations like Salesian Missions that allow us to be a small part of bringing these life-saving devices to those who need them most.”

“We appreciate this new partnership with Matter, which has enabled us to get critical medical supplies to places in need in Ukraine,” said Father Gus Baek, director of Salesian Missions. “Salesian organizations around the globe have come together to help support Salesians in Ukraine who are working with people displaced inside the country. This support is essential, especially now, when the warehouses of food and medicines in Ukraine are empty. The needs of people are increasing.”

Along with the medical supply shipment, Salesian Missions also sent a container of rice-meals from Feed My Starving Children, a nonprofit Christian organization committed to “feeding God’s children hungry in body and spirit.” The food is destined for poor residents of towns and villages in eastern Ukraine, where food is needed most.

In addition to these efforts, soon after the war started, Salesian Missions launched a Ukraine Emergency Relief Fund that is helping to provide shelter, nutrition and supplies to refugees in need. This fund is among other fundraising efforts that Salesians in more than 130 countries are doing in support of Salesians on the front lines of this crisis.

###

About Salesian Missions USA

Salesian Missions is headquartered in New Rochelle, NY, and is part of the Don Bosco Network—a worldwide federation of Salesian NGOs. The mission of the U.S.-based nonprofit Catholic organization is to raise funds for international programs that serve youth and families in poor communities around the globe. The Salesian missionaries are made up of priests, brothers and sisters, as well as laypeople—all dedicated to caring for poor children throughout the world in more than 130 countries and helping young people become self-sufficient by learning a trade that will help them gain employment. To date, more than 3 million youth have received services funded by Salesian Missions. These services and programs are provided to children regardless of race or religion. For more information, go to SalesianMissions.org.

Contact:

Hannah Gregory

media@salesianmissions.org

914-960-4642 (text messages OK)

Twitter: @MissionNewswire

Newswire: MissionNewswire.org

Press room: SalesianMissions.org/press

Newswire: MissionNewswire.org

Press room: SalesianMissions.org/press

Share article on social media or email:

Detection of COVID-19 Viral RNA in Wastewater as a Simple and Sensitive Method of Outbreak Detection in Large Populations, Upcoming Webinar Hosted by Xtalks


Due to highly automated procedures, all laboratory techniques are simple to use and can be performed by laboratory personnel with minimal training, and a turnaround time of a few hours.

During recent months, monitoring COVID-19 viral RNA in wastewater has been proposed as a method of detecting local outbreaks and has been implemented in several municipalities.

The advantages of this testing scheme are obvious: High test frequency (e.g., daily) monitoring of large populations; Elimination of reliance on individuals’ compliance; No underestimation of incidence; And cost reduction by establishing central testing points.

The global process and laboratory automation supplier Endress+Hauser, offers instrumental solutions for the entire workflow of detecting COVID-19 RNA in wastewater. An automatic wastewater sampler from the Endress+Hauser Liquistation product line is used to collect samples in defined time intervals. Viral RNA is then extracted and enriched on a membrane filter, which can be performed on site, and the filter is submitted to a laboratory for PCR-detection.

Analytik Jena, the laboratory division of Endress+Hauser, offers equipment and reagents for the extraction and purification of viral RNA, the preparation of purified samples for PCR analysis, as well as PCR thermal cyclers for simultaneous processing and analysis of up to 384 samples. All equipment used is scalable from single-sample processing up to an ultra-high throughput of thousands of samples per day.

This complete solution offers municipalities and industrial sites a unique turnkey solution from a single vendor, covering the entire workflow from sampling to detection and evaluation, for the early detection of local viral outbreaks. Due to highly automated procedures, all laboratory techniques are simple to use and can be performed by laboratory personnel with minimal training, and a turnaround time of a few hours.

The instrumentation used is based on an open platform concept, allowing high flexibility in the choice of third-party reagent kits. This also means that the system can easily be adapted to different pathogens, e.g., Salmonella, Listeria, or the currently emerging monkeypox.

Join Bretton Smith, MBS, Senior Field Applications Scientist, Analytik Jena US, for the live webinar on Wednesday, November 9, 2022, at 10am EST (4pm CET/EU-Central).

For more information, or to register for this event, visit Detection of COVID-19 Viral RNA in Wastewater as a Simple and Sensitive Method of Outbreak Detection in Large Populations.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Apollo’s Digital Pathology Solution arcc® Implemented at Temple University Health System


arcc for Pathology provides Temple Health with a solution that increases laboratory productivity and offers our Pathologists a high degree of flexibility in how Pathology imaging and related case information are managed and viewed enterprise-wide

Apollo, the leading provider of enterprise imaging and clinical multimedia management solutions, today announced that it has successfully deployed its Digital Pathology and enterprise imaging solution, arcc®, to support the management of Digital Pathology at Temple University Health System.

arcc for Pathology includes a focused workflow solution for Pathology to centrally and securely manage pathology images and their associated metadata. arcc provides a secure, web-based platform for remote telepathology consultations including live, remote microscopic viewing, multi-specialty collaboration, and enables device acquisition flexibility.

“arcc for Pathology provides Temple Health with a solution that increases laboratory productivity and offers our Pathologists a high degree of flexibility in how Pathology imaging and related case information are managed and viewed enterprise-wide,” said Christopher Burks, AVP, Laboratory Operations, Pathology & Laboratory Medicine, at Temple Health.

“We are honored and excited to be implemented at Temple Health with our arcc for Pathology solution,” said Mark Newburger, Apollo President and CEO. “As the Apollo Repository for Clinical Content, arcc, provides health systems and Pathology lab clinicians with access to its enterprise imaging solution, arcc, to support the workflows and management of Digital Pathology imaging to deliver positive care outcomes in a more efficient manner.”

About Apollo

Apollo is a healthcare IT company with a reputation for delivering quality Enterprise Imaging solutions that address both clinical multimedia workflow management needs and vendor neutral storage requirements. Apollo’s Enterprise Imaging solution, arcc, provides a holistic longitudinal view of all patient data and focuses on clinical workflows, interoperability, and connectivity so that every department throughout the enterprise can securely acquire, view, manage, store, and access all clinical content for “one patient view” through one platform. Used successfully in hospitals across the United States and Canada for over 28 years. Visit https://www.apolloei.com/ to learn more.

Share article on social media or email:

2022 ProSites Manager of the Year Award Winners Announced


ProSites logo

Andrea leads by example. As a manager she has always given me plenty of support as I continue to learn my position. She’s never too busy to lend an ear or helping hand. I respect Andrea as our manager because when all else fails she’s always there for each and every one of her team members.

In late 2021, ProSites decided to create the first ever ProSites Manager of the Year Award for 2022. “With everything that office managers contribute to their dental practices 24/7/365, we felt it was time to recognize these individuals in a very tangible way for all of their hard work – especially over the past few years,” said Luke Wilson, Chief Revenue Officer at ProSites.

In appreciation and celebration of dental office managers everywhere, the ProSites Manager of the Year Award was designed to highlight the incredible impact of office managers in their practices and the dental industry as a whole.

Now that nominations for the 2022 ProSites Manager of the Year Award have officially come to a close, we are pleased to announce that this year’s award winners are:

1st Place – Andrea Tinsley from Henderson Mill Dental Care in Atlanta, GA

2nd Place – Melissa Cortes from Gentle Family Dentistry in Dunkirk, MD

3rd Place – Sonia Desai from Seawall Dental in West Vancouver, BC

Andrea and the rest of this year’s winners are prime examples of how dental office managers go above and beyond to support and care for their teams and patients.

“Andrea leads by example. As a manager she has always given me plenty of support as I continue to learn my position. She’s never too busy to lend an ear or helping hand. I respect Andrea as our manager because when all else fails she’s always there for each and every one of her team members,” said another member of the Henderson Mill Dental Care team, Renee Dobbins.

“I feel she deserves this award because she shows true integrity and exceptional leadership. We are such a blessed team to have Andrea Tinsley as our manager!”

This year’s winners were announced during the American Association of Dental Office Managers Annual Conference (Sept 8-10) in Scottsdale, AZ, at the ProSites Booth. We want to personally thank each of our nominees for their efforts to improve their practices and the lives of their team members and patients.

Nominations for the 2023 ProSites Manager of the Year Award will open in Spring 2023. Visit https://www.ProSites.com for upcoming news on 2023 nominations, and the opportunity to nominate your office manager this coming spring!

About ProSites 

ProSites delivers innovative website design and digital marketing solutions to help dental and medical professionals build patient trust and improve patient care. The ProSites comprehensive suite of solutions includes ready-to-go and custom website design, search engine marketing, social media management, automated patient communications, and pay-per-click services. ProSites is trusted by over 7,500 dental practices and endorsed by 15 state dental associations. Learn more about ProSites by visiting https://www.ProSites.com or call (888) 932-3644.

Media Inquiries 

Tiffany Isbell 

VP of Brand and Content Marketing 

ProSites 

press@prosites.com 

Share article on social media or email:

Regal Introduces Special Mold & Die Components that are Custom Manufactured & Precision Ground to ±0.000050”


News Image

Regal Special Mold & Die Components can incorporate details including tapers, rings, vents, ribs and spirals shaped using wire EDM.

Suitable for a wide range of OEM requirements, Regal Special Mold & Die Components can be precision ground to a tolerance of ±0.000050” in lengths up to 14” L with tip diameters as small as 0.002”.

If you need custom core pins, sleeves, ejectors, blades, and punches, check with Regal Components, Inc. of East Providence, RI. They precision manufacture specials for leading manufacturers, distributors, and end-users.

Regal Special Mold & Die Components can be precision ground to a tolerance of ±0.000050” in lengths up to 14” L with tip diameters as small as 0.002”. Featuring surface finishes to 2 RMS, they can be custom manufactured from tool steels such as M-2, A-2, A-10, H-13, S-7, PM-M4, PM-10V, PM-15V, 420 and 440 stainless steels, and beryllium-free copper alloys, and can be polished, coated and plated for additional wear resistance and lubricity.

Suitable for a wide range of OEM requirements, Regal Special Mold & Die Components can incorporate details including tapers, rings, vents, ribs, and spirals shaped using wire EDM. Applications include molding a variety of medical, electronics, and consumer products that require extreme precision such as needles, sheaves, closures, nipples, pipettes, IV connectors, shavers, electronic components, and writing instruments.

Regal Special Mold & Die Components are priced according to material, configuration, and quantity. Price quotations are provided upon request.

For more information contact:

Regal Components, Inc.

Derek Coelho, VP Sales

10 Almeida Ave.

East Providence, RI 02914

(727) 299-0800 FAX (727) 499-7109

Email: sales@regalcomps.com

http://www.regalcomps.com

Share article on social media or email:

YorLabs Appoints Gregory D. Casciaro to Board of Directors


This team has very successful track records in medical device markets and in developing significant technology to enhance clinical results for millions of patients.

YorLabs, a developer of cutting-edge intracardiac image guided therapy solutions, today announced the appointment of Gregory “Greg” D. Casciaro to the company’s Board of Directors. Casciaro has 40 years of medical device experience and has held leadership roles in both public and private companies.

“We are pleased to welcome Greg to the YorLabs leadership team,” said Glen McLaughlin, president and CEO, YorLabs. “His extensive experience in the medical device industry, including several cardiac therapy solutions companies, will provide superb insights and guidance in our goal of developing the next generation, intracardiac image guided therapy platform.”

Casciaro is currently the president and CEO of Foldax Inc, the maker of Tria Heart Valves. Previously, he was the CEO, president and director of Cardiac Dimensions, as well as AccessClosure, Inc., a medical device company that was acquired by Cardinal Health. He also served in similar capacities at XTENT, a medical device company acquired by Biosensors International Group, and Orquest, a private company manufacturing and selling biotherapeutic products to the orthopedic market, which was acquired by DePuy Acromed, a division of Johnson and Johnson. He has been a member of the board of directors of QT Vascular Ltd., a Singaporean-listed company engaged in the design, assembly and distribution of therapeutic solutions for the minimally invasive treatment of complex vascular diseases, since 2001. Casciaro graduated from Marquette University with a B.S. in Business Administration.

“I joined the Yorlabs board, because of the high quality team Glen has assembled,” said Casciaro. “This team has very successful track records in medical device markets and in developing significant technology to enhance clinical results for millions of patients. It is exciting to join YorLabs in its endeavors to enable excellence in patient care.”

Today’s cath lab faces numerous challenges including capital constraints and disparate systems within the interventional cardiac (IC) and Electrophysiology (EP) markets. YorLabs’ vision is to provide a comprehensive, integrated therapy imaging solution with outstanding image quality and significantly improved workflow, while offering relief from large capital outlays and enabling ongoing, state-of-the art visualization.

To this end, YorLabs is designing its solution to provide automatic upgrades to maintain cutting-edge technology throughout the lifecycle of the platform. The company is developing novel algorithms to enable world class, intracardiac image guided therapy performance with dedicated application and procedural based settings and offerings. This solution will be an intuitive user interface platform, resulting in significant clutter and size reduction along with a greatly enhanced workflow.

“Greg is well qualified to serve on our board of directors,” said Anshumali Roy, founder and chief technology officer for YorLabs. “He has extensive management experience with growth companies and in mergers and acquisitions in the medical device industry – all of which will benefit YorLabs in successfully achieving its vision.”

About YorLabs

Today’s Cath Lab faces numerous challenges including capital constraints and disparate systems. YorLabs is developing a world class, intracardiac image guided therapy platform with dedicated application and procedural based settings. The YorLabs solution is designed to be an intuitive platform while eliminating large capital outlays and significantly enhancing workflow. For further information, visit http://www.yorlabs.com.

Share article on social media or email:

Moxie Scrubs Named in Fast Company’s Second Annual List of “Brands That Matter”


Moxie Scrubs Logo

Moxie Scrubs: Designed For Nurses, By Nurses

“It is an honor to be recognized by Fast Company for our meaningful work supporting nurses across the country. I feel so grateful that I get to build this amazing brand that supports nurses where they need the support the most.” – Moxie Scrubs’ Founder and CEO, Alicia Tulsee

Fast Company announced today its second annual “BrandsThat Matter” list, honoring brands that communicate and demonstrate brand purpose. These companies and nonprofits have achieved relevance through cultural impact and social engagement, and authentically communicated their missions and ideals.

The final list, which includes large multinational conglomerates, small-but-mighty companies, and nonprofits, recognizes 145 brands that give people compelling reasons to care about them—and offer inspiration for others to buy in. All 145 have found an ability to forge an emotional connection with customers, whether leading on the environment or pop culture, engaging B2B customers, or responding meaningfully to current events.

All brands that applied were considered for overall recognition. Additionally, there are also honorees on category-specific lists based on region, size, and status.

“This year, we’ve expanded the Brands That Matter program to evaluate honorees in the context of how they matter within the category in which they compete for people’s attention or loyalty. The result is a wide-ranging list of honorees that are making their mark on culture, and through social impact,” said Brendan Vaughan, Fast Company’s editor-in-chief.

“Entrepreneurship gives you the opportunity to take your life in directions you would never think could be possible. And it’s even more beautiful when your business helps to improve the lives of millions of people across the country,” explains Moxie Scrubs’ Founder and CEO, Alicia Tulsee. “It is an honor to be recognized by Fast Company for our meaningful work supporting nurses across the country. I feel so grateful that I get to build this amazing brand that supports nurses where they need the support the most.”

The idea for Moxie Scrubs was developed in Harvard University’s Innovation Lab in 2019 when Alicia couldn’t seem to find a brand dedicated to nurses and their unique performance needs, despite nurses being the largest and fastest-growing segment of the healthcare workforce with significantly different needs compared to other roles in healthcare. This gave birth to their mission to create a lifestyle brand made by nurses for nurses where every design is named after the nurse who worked with their design team to create the scrubs they want to wear, building a strong community and inclusivity around the brand to become a beacon for nurse culture.

Less than two years later, CEO Alicia Tulsee was named on the 2021 Forbes Next 1000 List, spotlighting the dedication she had not only to building this brand, but also her continuous support of the nursing community as the COVID-19 pandemic revealed the unwavering courage of frontline heroes around the world.

By early 2022, Tulsee surpassed her goals and single-handedly raised over $2.4 million dollars in pre-seed funding for Moxie Scrubs. In the process of doing so, she found herself recognized once again, this time by ForbesWomen for her tenacity and drive to push forward through any obstacle that stood in her way of achieving the goals she set for Moxie Scrubs.

Fast Company editors judged each brand on relevancy, cultural impact, ingenuity, and business impact to compile the list.

Click here to see the complete list.

The November issue of Fast Company magazine is available online now and will be on newsstands beginning November 1, 2022.

About Fast Company

Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. The editor-in-chief is Brendan Vaughan. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication, Inc., and can be found online at fastcompany.com.

About Moxie Scrubs

Born out of Harvard’s Innovation Lab, Moxie Scrubs is disrupting the medical apparel market as the first direct-to-consumer lifestyle brand for nurses, by nurses. Boston-based Moxie Scrubs was founded by Alicia Tulsee, a native New Yorker and Harvard alum. In awe of all of the amazing nurses who cared for her loved ones, Alicia felt a calling to do something meaningful for the nursing profession. ‘Moxie’ defines the ‘force of character, determination, and resourcefulness,’ of the nurses across our country on the frontlines today. More than a brand, this is a movement. For more information, visit http://www.moxiescrubs.com

Share article on social media or email:

BlueDot announces new leadership as it prepares for rapid growth in 2023


BlueDot is pleased to welcome Dr. Andrea Thomas, Jannine Krish and Les Lengyel to the leadership team.

BlueDot’s newly appointed leadership team comes at a time when the market need for infectious disease intelligence is rising, so governments and private sector organizations can make critical decisions with more agility and better insights.

BlueDot Inc., the leading artificial and human intelligence organization for detecting, assessing, and responding to global infectious diseases, announced the expansion of its executive team as it enters its next phase of growth. As part of the company’s continued work in building private and public sectors’ resiliency to outbreaks, BlueDot announced the hires of Les Lengyel, Vice President of Sales and Jannine Krish, Vice President of Marketing, in addition to the promotion of Dr. Andrea Thomas to Director of Epidemiology.

Les Lengyel is a tenured leader in the AI SaaS, Life Sciences and MedTech sectors, and brings to BlueDot a keen ability to drive significant growth having achieved revenue increases year over year and tripled purchase order growth in previous roles. With over a decade in Philips Healthcare and Roche respectively alone, he brings a critical understanding of how to drive successful key initiatives and company growth.

Jannine Krish is an experienced marketing leader with 15 years of experience in building and scaling iconic Canadian startups and enterprise brands on a global stage. Through a combination of storytelling and performance marketing, she’s led marketing strategies that build industry leadership, consumer trust and business results. Jannine has held senior marketing roles at Flybits, Union Pearson Express and Porter Airlines.

Dr. Andrea Thomas has been a predominant figure in driving excellence in epidemiology at BlueDot over the past five years. She led the data science team in introducing innovative approaches to data science throughout the pandemic and maintains academic excellence with frequent publications, including the world’s first publication on COVID-19 and a publication estimating potential global exportation of monkeypox. Dr. Thomas holds a Doctor of Veterinary Medicine degree, along with a Masters and PhD in Epidemiology.

“Our company went through a rapid phase of growth during the height of the COVID 19 pandemic,” said Dr. Kamran Khan, Founder and CEO, BlueDot. “Now as we prepare for this next phase of growth, I’m excited about deepening our pool of talented leaders to expand our global reach and impact.”

BlueDot’s newly appointed leadership team comes at a time when the market need for infectious disease intelligence is rising, so governments and private sector organizations can make critical decisions with more agility and better insights.

About BlueDot

BlueDot’s intelligence platform empowers public and private sector organizations to rapidly identify, understand, and effectively respond to global biothreats. Combining human and artificial intelligence to track hundreds of infectious diseases and syndromes worldwide, it applies academic data science expertise to anticipate global spread and impact. BlueDot ensures clients know first when disease events emerge, are prepared to respond, can focus on what matters, and can act swiftly and confidently when needed. Founded in 2013 and used by the City of Chicago, Taiwan CDC, Air Canada and more, BlueDot helps clients make critical decisions with clarity and confidence. Learn more at http://www.bluedot.global

Share article on social media or email:

HeardThat Recognized as Runner-up at AGE-WELL National Impact Challenge 2022 for Improving Intelligibility of Conversations in Loud Places for Aging Population


News Image

Singular Hearing, a subsidiary of Singular Software and creator of HeardThat, today announced it gained the runner-up distinction at the AGE-WELL National Impact Challenge 2022 for its hearing-assistive, AI-powered app. HeardThat was one of six finalists that pitched their innovation at the AGE-WELL Annual Conference, a Canadian conference discussing current issues and innovations in the field of technology and aging.

HeardThat was recognized for success in improving the health and quality of life of older adults by enhancing intelligibility and reducing listening effort for those that have trouble hearing conversations in loud places, like restaurants or social gatherings. Since its early release, HeardThat has gained thousands of regular users.

“It’s an honor to be recognized by AGE-WELL, along with the other outstanding finalists,” said Singular Hearing CEO and HeardThat Founder Bruce Sharpe. “We created HeardThat to solve a very common hearing ability challenge and empower users to hear more speech, less noise. Thank you, AGE-WELL for the accolades and an inspiring conference.”

“HeardThat’s use of artificial intelligence to help people stay socially connected really changes the game for hearing-assistive AgeTech,” said Michael Chrostowski, PhD, Senior Manager, Business Development and Industry Relations, AGE-WELL. “We’re proud to honor HeardThat and Singular Hearing for their work, and we know they’ll continue to gain popularity.”

For more information on HeardThat, please visit heardthat.ai.

About Singular Hearing

Singular Hearing is a subsidiary of Singular Software. Founder and CEO Bruce Sharpe and his team of AI experts have extensive experience in audio technology and a deep passion for finding effective solutions to everyday problems. They leverage machine learning and speech processing to create innovative products that help people live better by hearing better.

Singular Hearing is the creator of HeardThat, an award-winning innovative app that turns smartphones into sophisticated hearing-assistive devices. HeardThat helps those with hearing challenges by delivering clear speech in noisy environments.

HeardThat was named runner-up at the AGE-WELL National Impact Challenge 2022. The app also won the What’s Next Innovation Challenge Sponsored by AARP Innovation Labs at the 17th Annual What’s Next Longevity Venture Summit and was named the first runner-up in the What’s Next Business Plan Competition at the 17th What’s Next Longevity Venture Summit. For more information, please visit heardthat.ai.

Share article on social media or email:

Innovation Fertility Launches Reproductive Specialists of the Carolinas


Innovation Fertility, a network of leading IVF clinics and laboratories, today announced that it has partnered with a Charlotte-based reproductive endocrinologist to offer advanced fertility treatments under the name of Reproductive Specialists of the Carolinas. The new clinic is led by Dr. Matrika Johnson, a dual board-certified OB/GYN and reproductive endocrinologist recently recognized as one of Charlotte’s “Top Doctors” by Charlotte Magazine. The investment in Reproductive Specialists of the Carolinas anchors Innovation Fertility’s commitment to offering state-of-the-art reproductive services in the Charlotte market. The financial terms of the deal were not disclosed.

Reproductive endocrinology is among the fastest-growing medical specialties. Demand for advanced fertility care will continue to rise as couples are deciding to have children later in life and the prevalence of male infertility, driven by environmental and lifestyle factors, increases. Further trends favoring industry demand are a growing percentage of same-sex couples desiring children and an increasing number of employers offering benefits for IVF and genetic testing services.

“We are thrilled to have Dr. Johnson leading our Charlotte office,” explained Dwight P. Ryan, CEO of Innovation Fertility. He continued, “Dr. Johnson is incredibly passionate about helping people build families. Her extensive knowledge and her intimate, personalized approach to patient care are completely aligned with our goal of providing the most advanced treatment options and the best patient care. Together, we look forward to leading the way in innovative and patient-centric fertility care in North Carolina.”

“Working with Innovation Fertility helped me design a premiere boutique REI practice,” said Dr. Johnson. “They helped with everything from clinical and laboratory design, purchasing all equipment and providing trained staff.”

ABOUT DR. MATRIKA D. JOHNSON

Matrika D. Johnson, M.D., is board-certified in Obstetrics and Gynecology as well as Reproductive Endocrinology and Infertility. Since 2020, Dr. Johnson has appeared in Charlotte Magazine’s list of the Top Doctors in Charlotte for reproductive endocrinology and infertility.

ABOUT INNOVATION FERTILITY

Innovation Fertility provides patients with innovative, cutting-edge fertility treatment options to meet their unique family planning goals. As a team, they combine premier reproductive endocrinologists with laboratory operations, resulting in exceptional medical care and an unparalleled patient experience.

FORWARD-LOOKING STATEMENT

This communication expressly or implicitly contains certain forward-looking statements that involve risks and uncertainties, including statements regarding expectations for Reproductive Specialists of the Carolinas following its acquisition by Innovation Fertility. If any of these risks or uncertainties materialize, or if any of Reproductive Specialists of the Carolinas’ or Innovation Fertility’s assumptions prove incorrect, Reproductive Specialists of the Carolinas’ results could differ materially from the results expressed OR implied by these forward-looking statements. All forward-looking statements in this communication are based on information available to Reproductive Specialists of the Carolinas and Innovation Fertility as of the date of this communication, and Reproductive Specialists of the Carolinas and Innovation Fertility do not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

Share article on social media or email: